Produkty 2691096-32-7

CAS 2691096-32-7 występuje w naszej ofercie pod nazwami: (±)–Cannabichromebutolic Acid, (±)-Cannabichromebutolic acid. Oferty producentów: GLPBio, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 5 mg, 1 mg.

(±)–Cannabichromebutolic Acid
GLPBio
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 1458,25
Zobacz produkt
(±)-Cannabichromebutolic acid
MedChemExpress
  • opakowanie: 5 mg, 1 mg
  • Warianty: 2
od 2353,76
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

7-butyl-5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)chromene-6-carboxylic acid (CAS 2691096-32-7) to związek chemiczny o wzorze sumarycznym C21H28O4 i masie molowej 344.4 g/mol. Nazwa systematyczna IUPAC: 7-butyl-5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)chromene-6-carboxylic acid. InChIKey: LBLHSYKUFLXTQM-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H28O4
Masa molowa344.4 g/mol
Nazwa IUPAC7-butyl-5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)chromene-6-carboxylic acid
InChIKeyLBLHSYKUFLXTQM-UHFFFAOYSA-N
SMILESCCCCC1=CC2=C(C=CC(O2)(C)CCC=C(C)C)C(=C1C(=O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (+/-)-Cannabichromebutolic Acid, (+/-)-CBCB, nor-Cannabichromene, (?)-Cannabichromebutolic Acid, ( inverted exclamation markA)-Cannabichromebutolic acid
Powiązane formy tego związku
7-butyl-5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)chromene-6-carboxylic acid C21H28O4
Izomery (ten sam wzór sumaryczny)
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7,17-dioxo-2,3,4,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C21H28O4
2-[(8S,9R,10R,11S,13S,14R,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C21H28O4
(6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-17-carboxylic acid C21H28O4
(8S,9S,10R,11S,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O4
2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetic acid C21H28O4
(8S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one C21H28O4
(7R,8S,9S,10S,13S,14S,17R)-17-ethynyl-10-hydroperoxy-17-hydroxy-7,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H28O4
(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H28O4
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O4
1-[4-[2-[4-(2-hydroxypropoxy)phenyl]propan-2-yl]phenoxy]propan-2-ol C21H28O4
(8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C21H28O4